InvestorsHub Logo
Followers 61
Posts 7532
Boards Moderated 2
Alias Born 02/10/2010

Re: Echo20 post# 110633

Friday, 04/24/2015 9:35:43 AM

Friday, April 24, 2015 9:35:43 AM

Post# of 146228
We keep right on circling back to that same sticking point here Echo (and others).

Seems like they and NNVC could have made an herpes cream by now. Maybe someone else will enter the scene and take over on HERPESCIDE CREAM and get that to higher than acadamia (sic) speed and into the market place and sell in stores.



My guess is that efficacy of the compounds (both then and now) and recognition that it 'could' be done (and probably should have been done ASAP) back then have hit the same wall.

Until 'Cides (generic form and not just Flucide) can be produced on sufficient scale to actually make a product in useful market quantities (aside from what yet needs to be made for Flucide TOX testing) - it can't be done.

Everything keeps circling back to the problem they are tackling in Shelton now,.... scale-up and (more importantly) scale-up with good QC results.

A partnership with a real manufacturer of medicines. Someone like Johnson and Johnson or others.



While I think in the long-run - something like this is going to have to be done,... a company like J&J or it's market competitors isn't going to take on manufacturing somebody else's compounds until they:

1) Have enough clinical evidence to indicate it actually is likely to work (we have nil clinical evidence yet).

2) They at NNVC have the scale-up process sufficiently 'cook booked' that one of the big guys can just follow the existing recipe and not have to do the optimization themselves.

“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News